Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Receives $21.25 Consensus PT from Analysts
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV – Get Free Report) has been given an average recommendation of “Buy” by the six research firms that are covering the firm, MarketBeat.com reports. Six research analysts have rated the stock with a buy rating. The average 1 year target price among brokers that have updated their coverage on the stock […]
More Stories
CleanSpark (NASDAQ:CLSK) Shares Down 4.4% – Here’s Why
CleanSpark, Inc. (NASDAQ:CLSK – Get Free Report)’s stock price fell 4.4% during trading on Tuesday . The stock traded as...
NIO (NYSE:NIO) Trading Down 2.5% – What’s Next?
Nio Inc – (NYSE:NIO – Get Free Report) was down 2.5% during mid-day trading on Tuesday . The company traded...
UnitedHealth Group (NYSE:UNH) Shares Up 0.1% – Still a Buy?
UnitedHealth Group Incorporated (NYSE:UNH – Get Free Report) shares rose 0.1% on Tuesday . The company traded as high as...
Birch Capital Management LLC Has $566,000 Stake in Antero Midstream Co. (NYSE:AM)
Birch Capital Management LLC increased its position in Antero Midstream Co. (NYSE:AM – Free Report) by 1.8% during the fourth...
JPMorgan Chase & Co. Cuts Webster Financial (NYSE:WBS) Price Target to $65.00
Webster Financial (NYSE:WBS – Get Free Report) had its price target reduced by equities researchers at JPMorgan Chase & Co....
Chevron (NYSE:CVX) Trading Up 1.8% – Should You Buy?
Chevron Co. (NYSE:CVX – Get Free Report) was up 1.8% during mid-day trading on Tuesday . The company traded as...